European Heart Journal-Quality of Care and Clinical Outcomes

Article	Citations
Admission of patients with STEMI since the outbreak of the COVID-19 pandemic: a survey by the European Society of Cardiology	167
Global, regional, and national burden of ischaemic heart disease and its attributable risk factors, 1990–2017: results from the Global Burden of Disease Study 2017	147
Global, regional, and national prevalence, incidence, mortality, and risk factors for atrial fibrillation, 1990–2017: results from the Global Burden of Disease Study 2017	118
Atrial fibrillation in the UK: predicting costs of an emerging epidemic recognizing and forecasting the cost drivers of atrial fibrillation-related costs	105
The impact of the COVID-19 pandemic on the care and management of patients with acute cardiovascular disease: a systematic review	103
Patient response, treatments, and mortality for acute myocardial infarction during the COVID-19 pandemic	68
Emergency hospital admissions and interventional treatments for heart failure and cardiac arrhythmias in Germany during the Covid-19 outbreak: insights from the German-wide Helios hospital network	58
Impact of COVID-19 on cardiac procedure activity in England and associated 30-day mortality	50
Substantial decline in hospital admissions for heart failure accompanied by increased community mortality during COVID-19 pandemic	49
Where have the ST-segment elevation myocardial infarctions gone during COVID-19 lockdown?	46
Two-year outcomes of more than 30 000 elderly patients with atrial fibrillation: results from the All Nippon AF In the Elderly (ANAFIE) Registry	45
European Society of Cardiology methodology for the development of quality indicators for the quantification of cardiovascular care and outcomes	43
Cardiovascular comorbidities as predictors for severe COVID-19 infection or death	40
Acute coronary syndromes undergoing percutaneous coronary intervention in the COVID-19 era: comparable case volumes but delayed symptom onset to hospital presentation	40
Cost-effectiveness of low-dose colchicine after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)	39
Cardiovascular risk factors, cardiovascular disease, and COVID-19: an umbrella review of systematic reviews	34
European Society of Cardiology: cardiovascular disease statistics 2021: Executive Summary	31
Peak oxygen consumption achieved at the end of cardiac rehabilitation predicts long-term survival in patients with coronary heart disease	27
Types of myocardial injury and mid-term outcomes in patients with COVID-19	27
Impact of frailty on outcomes in elderly patients with acute myocardial infarction who undergo percutaneous coronary intervention	25
Myocarditis and pericarditis in adolescents after first and second doses of mRNA COVID-19 vaccines	24
The cost-effectiveness of transcatheter aortic valve replacement in low surgical risk patients with severe aortic stenosis	24
Refined staging classification of cardiac damage associated with aortic stenosis and outcomes after transcatheter aortic valve implantation	23
Pneumococcal vaccination in adults at very high risk or with established cardiovascular disease: systematic review and meta-analysis	23
Predictors of pacemaker implantation after transcatheter aortic valve implantation according to kind of prosthesis and risk profile: a systematic review and contemporary meta-analysis	23

Improving dynamic stroke risk prediction in non-anticoagulated patients with and without atrial fibrillation: comparing common clinical risk scores and machine learning algorithms	21
Low-density lipoprotein cholesterol levels exceed the recommended European threshold for PCSK9i initiation: lessons from the HEYMANS study	21
A comparative analysis of premature heart disease- and cancer-related mortality in women in the USA, 1999–2018	20
GARFIELD-AF risk score for mortality, stroke, and bleeding within 2 years in patients with atrial fibrillation	19
Cumulative hospitalization deficit for cardiovascular disorders in Germany during the COVID-19 pandemic: insights from the German-wide Helios hospital network	18
Management of aortic stenosis: a systematic review of clinical practice guidelines and recommendations	18
The SWEDEHEART secondary prevention and cardiac rehabilitation registry (SWEDEHEART CR registry)	16
Shared decision-making in atrial fibrillation: patient-reported involvement in treatment decisions	16
A marker of systemic inflammation or direct cardiac injury: should cardiac troponin levels be monitored in COVID-19 patients?	16
Representativeness in randomised clinical trials supporting acute coronary syndrome guidelines	16
Poor adherence to guideline-directed anticoagulation in elderly Chinese patients with atrial fibrillation: a report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrilla	16
Ethnic disparities in care and outcomes of non-ST-segment elevation myocardial infarction: a nationwide cohort study	15
Cost-effectiveness analysis of screening for first-degree relatives of patients with bicuspid aortic valve	15
Cardiac rehabilitation for patients with heart failure: association with readmission and mortality risk	15
Should fractional flow reserve follow angiographic visual inspection to guide preventive percutaneous coronary intervention in ST-elevation myocardial infarction?	15
The independent reduction in mortality associated with guideline-directed medical therapy in patients with coronary artery disease and heart failure with reduced ejection fraction	14
Comparative overview of ST-elevation myocardial infarction epidemiology, demographics, management, and outcomes in five Asia-Pacific countries: a meta-analysis	14
Development of an international standard set of clinical and patient-reported outcomes for children and adults with congenital heart disease: a report from the International Consortium for Health Outc	14
Percutaneous vs. surgical revascularization for patients with unprotected left main stenosis: a meta-analysis of 5-year follow-up randomized controlled trials	14
Methodology for the development of international clinical data standards for common cardiovascular conditions: European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart)	13
Comparison of HAS-BLED and ORBIT bleeding risk scores in atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants: a report from the ESC-EHRA EORP-AF General Long-Term Re	13
Temporal trends of mortality in patients with infective endocarditis: a nationwide study	13
Predicting the EQ-5D utilities from the Kansas City Cardiomyopathy Questionnaire in patients with heart failure	13
Does objectively measured light-intensity physical activity reduce the risk of cardiovascular mortality? A meta-analysis	13
Improved clinical investigation and evaluation of high-risk medical devices: the rationale and objectives of CORE-MD (Coordinating Research and Evidence for Medical Devices)	13
The effect of mental health conditions on the use of oral anticoagulation therapy in patients with atrial fibrillation: the FinACAF study	13
Cohort profile: the ESC EURObservational Research Programme Atrial Fibrillation III (AF III) Registry	13
Temporal trends in disease-specific causes of cardiovascular mortality amongst patients with cancer in the USA between 1999 and 2019	12
Sex differences in mortality and 90-day readmission rates after transcatheter aortic valve replacement: a nationwide analysis from the USA	12
Sex differences in the etiology and burden of heart failure across country income level: analysis of 204 countries and territories 1990–2019	11
Cost-effectiveness of proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab in patients with a history of myocardial infarction in Sweden	11
Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Progr	11
Global representation of heart failure clinical trial leaders, collaborators, and enrolled participants: a bibliometric review 2000–20	11
Health impact of tafamidis in transthyretin amyloid cardiomyopathy patients: an analysis from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and the open-label long-term exten	11
European Society of Cardiology quality indicators for the prevention and management of cancer therapy-related cardiovascular toxicity in cancer treatment	11
Should oral anticoagulants still be prescribed to patients with atrial fibrillation with a single stroke risk factor but at high bleeding risk? A nationwide cohort study	11
Generalizability of randomized controlled trials in heart failure with reduced ejection fraction	11
Has the first year of the COVID-19 pandemic reversed the trends in CV mortality between 1999 and 2019 in the United States?	11
Shared decision-making: the patient on the forefront of care coordination	10
Utilization of diagnostic resources and costs in patients with suspected cardiac chest pain	10
High-statin adherence over 5 years of follow-up is associated with improved cardiovascular outcomes in patients with atherosclerotic cardiovascular disease: results from the IMPRES study	10
Transcatheter aortic valve replacement in mixed aortic valve disease: a systematic review and meta-analysis	10
Patient-reported outcome measures in cardiovascular disease	10
Meta-analysis of the Placebo and Nocebo effects associated with Placebo treatment in randomized trials of lipid-lowering therapies	10
Effect of coronary artery bypass grafting on quality of life: a meta-analysis of randomized trials	10
Alerting trends in epidemiology for calcific aortic valve disease, 1990–2019: An age–period–cohort analysis for the Global Burden of Disease Study 2019	10
Comparison of management and outcomes of ST-segment elevation myocardial infarction patients in Estonia, Hungary, Norway, and Sweden according to national ongoing registries	10
Clinical event reductions in high-risk patients after renal denervation projected from the global SYMPLICITY registry	10
EURObservational Research Programme: a bibliometric assessment of its scientific output	10
Ten-year trends in mortality and complications following catheter ablation of atrial fibrillation	10

Comparative efficacy and safety of different catheter ablation strategies for persistent atrial fibrillation: a network meta-analysis of randomized clinical trials	9
Machine learning-based identification of risk-factor signatures for undiagnosed atrial fibrillation in primary prevention and post-stroke in clinical practice	9
Stroke prevention with direct oral anticoagulants in high-risk elderly atrial fibrillation patients at increased bleeding risk	9
The association between cardiovascular disease admission rates and the coronavirus disease 2019 lockdown and reopening of a nation: a Danish nationwide cohort study	9
The burden of atherosclerosis in Portugal	9
Targeted vs. full population screening costs for incident atrial fibrillation and AF-related stroke for a healthy population aged 65 years in the United Kingdom	9
Poor quality of life in patients with and without frailty: co-prevalence and prognostic implications in patients undergoing percutaneous coronary interventions and cardiac catheterization	9
Statin dose titration patterns and subsequent major cardiovascular events in very high-risk patients: estimates from Swedish population-based registry data	9
Treatment of older patients with atrial fibrillation by morbidity burden	9
Gender differences in complications following catheter ablation of atrial fibrillation	8
Impact of cancer diagnosis on distribution and trends of cardiovascular hospitalizations in the USA between 2004 and 2017	8
Utilization of sacubitril/valsartan in patients with heart failure with reduced ejection fraction: real-world data from the ARIADNE registry	8
Sodium-glucose cotransporter 2 inhibitors in patients with heart failure: a systematic review and meta-analysis of randomized trials	8
The influence of the 2020 COVID-19 pandemic on the implantation rates of cardiac implantable electronic devices in Germany: changes between 2020 Q1–Q3 and 2019 Q1–Q3	8
Long-term clinical outcomes after major bleeding in patients with atrial fibrillation: the Fushimi AF registry	8
Evaluating the diagnostic and prognostic value of biomarkers for heart disease and major adverse cardiac events in patients with muscular dystrophy	8
Venoarterial extracorporeal membrane oxygenation (VA-ECMO) with vs. without left ventricular unloading by Impella: a systematic review and meta-analysis	8
Estimating the cost-effectiveness of screening a general population for cardiovascular risk with high-sensitivity troponin-I	7
Which frailty tool best predicts morbidity and mortality in ambulatory patients with heart failure? A prospective study	7
Effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in atrial fibrillation: a Scandinavian population-based cohort study	7
Time to benefit and harm of intensive blood pressure treatment: insights from SPRINT	7
A tale of two countries: how decentralized organization and long-term investment build resilient healthcare systems	7
Will the COVID-19 epidemic reshape cardiology?	7
Socioeconomic variations determine the clinical presentation, aetiology, and outcome of infective endocarditis: a prospective cohort study from the ESC-EORP EURO-ENDO (European Infective Endocarditis)	7
Door-to-balloon time and mortality in patients with ST-elevation myocardial infarction undergoing primary angioplasty	7
Quality indicators in the management of elderly Chinese patients with atrial fibrillation: a report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF)	6
Association between changes in body weight and lipid profile in the general population: a community-based cohort study	6
Prospective validation of the AUB-HAS2 cardiovascular risk index	6
Longitudinal management and outcomes of acute coronary syndrome in persons living with HIV infection	6
Study design, result posting, and publication of late-stage cardiovascular trials	6
Management of mitral stenosis: a systematic review of clinical practice guidelines and recommendations	6
COMPASS criteria applied to a contemporary cohort of unselected patients with stable coronary artery diseases: insights from the START registry	6
Cohort profile: the ESC EURObservational Research Programme Non-ST-segment elevation myocardial infraction (NSTEMI) Registry	6
Impact of the admitting ward on care quality and outcomes in non-ST-segment elevation myocardial infarction: insights from a national registry	6
Importance of diagnostic setting in determining mortality in patients with new-onset heart failure: temporal trends in Denmark from 1997 to 2017	6
Cardiovascular disease burden due to productivity losses in European Society of Cardiology countries	5
Trends in treatment and outcomes of atrial fibrillation during 2007–17 in Finland	5
Safety and efficacy of different P2Y12 inhibitors in patients with acute coronary syndromes stratified by the PRAISE risk score: a multicentre study	5
Safety and efficacy of direct oral anticoagulants in patients with anaemia and atrial fibrillation: an observational nationwide Danish cohort study	5
The cost-effectiveness of one-time opportunistic screening for atrial fibrillation in different age cohorts of inhabitants in Denmark aged 65 years and above: a Markov modelled analysis	5
Causes, pattern, predictors, and prognostic implications of new hospitalizations after transcatheter aortic valve implantation: a long-term nationwide observational study	5
The PRECISE-DAPT score and 5-year outcomes after percutaneous coronary intervention: a large-scale, real-world study from China	5
Left atrial appendage occlusion in the UK: prospective registry and data linkage to Hospital Episode Statistics	5
Temporal trends in major cardiovascular events following first-time myocardial infarction in the reperfusion era – a Danish nationwide cohort study from 2000 to 2017	5
Potential for optimizing management of obesity in the secondary prevention of coronary heart disease	5
Concurrent use of P-glycoprotein or Cytochrome 3A4 drugs and non-vitamin K antagonist oral anticoagulants in non-valvular atrial fibrillation	5
Adherence to risk-assessment protocols to guide computed tomography pulmonary angiography in patients with suspected pulmonary embolism	5
Atrial fibrillation and chronic obstructive pulmonary disease: diagnostic sequence and mortality risk	5
Admission rates and care pathways in patients with atrial fibrillation during the COVID-19 pandemic—insights from the German-wide Helios hospital network	5
Case-ascertainment of acute myocardial infarction hospitalizations in cancer patients: a cohort study using English linked electronic health data	5
Racial differences in the aetiology of mitral valve disease	4
Targeted atrial fibrillation detection in COVID-19 vaccination clinics	4
Association between cancer, CHA2DS2VASc risk, and in-hospital ischaemic stroke in patients hospitalized for atrial fibrillation	4
A hidden problem: peripheral artery disease in women	4
Economic evaluation of restrictive vs. liberal transfusion strategy following acute myocardial infarction (REALITY): trial-based cost–effectiveness and cost–utility analyses	4
Impact of frailty on the effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a nationwide cohort study	4
Health Outcomes Management Evaluation—A National Analysis of Dutch Heart Care	4
Myocardial injury: a future challenge for long-COVID-19 complications	4
Serum potassium as a predictor of adverse clinical outcomes in patients with increasing comorbidity burden	4
Cost-effectiveness ofCYP2C19-guided P2Y12 inhibitors in Veterans undergoing percutaneous coronary intervention for acute coronary syndromes	4
Which risk score best predicts cardiovascular outcome in pregnant women with congenital heart disease?	4
Cardiology after COVID-19: Quo Vademus?	4
Predictors of cumulative cost for patients with severe aortic stenosis referred for surgical or transcatheter aortic valve replacement: a population-based study in Ontario, Canada	4
Transradial versus transfemoral approach for percutaneous coronary intervention in patients with ST-elevation myocardial infarction complicated by cardiogenic shock: a systematic review and meta-analy	4
De-frailing intervention for hospitalized cardiovascular patients in the TARGET-EFT randomized clinical trial	4
Diabetes mellitus and outcomes of lower extremity revascularization for peripheral artery disease	4
A systematic assessment of the characteristics of randomized controlled trials cited by acute coronary syndrome clinical practice guidelines	4
Critical Care Cardiology Trials Network (CCCTN): a cohort profile	4
Prognostic value of modified model for end-stage liver disease scores in patients with significant tricuspid regurgitation	4
β-blocker adherence among patients with congenital long QT syndrome: a nationwide study	4
Patient-reported vs. physician-estimated symptoms before and after transcatheter aortic valve replacement	4
Cost-effectiveness of bilateral vs. single internal thoracic artery grafts at 10 years	4
True-severe stenosis in paradoxical low-flow low-gradient aortic stenosis: outcomes after transcatheter aortic valve replacement	4
Tricuspid regurgitation management: a systematic review of clinical practice guidelines and recommendations	4
Differences in characteristics, treatments and outcomes in patients with non-ST-elevation myocardial infarction: novel insights from four national European continuous real-world registries	4
Temporal trends and socioeconomic differences in the incidence of left-sided valvular heart disease in Denmark	4
Quality improvement initiative in paediatric echocardiography laboratory in a low- to middle-income country	4
The association between urinary sodium concentration (UNa) and outcomes of acute heart failure: a systematic review and meta-analysis	4
Sex disparity in secondary prevention pharmacotherapy and clinical outcomes following acute coronary syndrome	3
Real world evidence: Perspectives from a European Society of Cardiology Cardiovascular Round Table with contribution from the European Medicines Agency	3

The importance of considering both primary and secondary diagnostic codes when using administrative health data to study acute coronary syndrome epidemiology (ANZACS-QI 47)	3
New York Heart Association class is strongly associated with mortality beyond heart failure in symptomatic women	3
Outcomes of ST elevation myocardial infarction in patients with cancer: a nationwide study	3
Incidence of myocardial infarction, heart failure, and cardiovascular mortality in patients with peripheral artery disease: trends between 1997 and 2016	3
Association of admitting physician specialty and care quality and outcomes in non-ST-segment elevation myocardial infarction (NSTEMI): insights from a national registry	3
Tuning and external validation of an adult congenital heart disease risk prediction model	3
Implications of structural right ventricular involvement in patients with hypertrophic cardiomyopathy	3
Cause-specific death and risk factors of 1-year mortality after implantable cardioverter-defibrillator implantation: a nationwide study	3
Freedom from atrial arrhythmia and other clinical outcomes at 5 years and beyond after catheter ablation of atrial fibrillation: a systematic review and meta-analysis	3
Real-world management and outcomes of 7 million patients with acute coronary syndrome according to clinical research trial enrolment status: a propensity matched analysis	3
Left ventricular thrombus in ischaemic heart disease: diagnosis, treatment, and gaps of knowledge	3
Are non-invasive estimations of plasma volume an accurate measure of congestion in patients with chronic heart failure?	3
Update on long-term cardiovascular risk after pre-eclampsia: a systematic review and meta-analysis	3
Sex differences in temporal trends in main and secondary pulmonary embolism diagnosis and case fatality rates: 2003–2019	3
The cost-effectiveness of rivaroxaban with or without aspirin in the COMPASS trial	3
Optimal Heart Team Protocol to Improve Revascularization Decisions in Patients with Complex Coronary Artery Disease: A Sequential Mixed Method Study	3
Do we need to reconsider how we design and conduct randomized controlled trials?	3
Health-related quality-of-life up to one year after myocardial infarction with non-obstructive coronary arteries	3
Relationship between remnant cholesterol and risk of heart failure in participants with diabetes mellitus	3
Predictive value of post-percutaneous coronary intervention fractional flow reserve: a systematic review and meta-analysis	3
Health economic consequences of optimal vs. observed guideline adherence of coronary angiography in patients with suspected obstructive stable coronary artery in Germany: a microsimulation model	3
Relationship between remnant cholesterol and risk of heart failure in participants with diabetes mellitus: Reply	3
Occlusion of the infarct-related coronary artery presenting as acute coronary syndrome with and without ST-elevation: impact of inflammation and outcomes in a real-world prospective cohort	3
What is next for screening for undiagnosed atrial fibrillation? Artificial intelligence may hold the key	2
Clinical risk prediction models for the prognosis and management of acute coronary syndromes	2
Data standards for atrial fibrillation/flutter and catheter ablation: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart)	2
Long-term outcome of children with newly diagnosed pulmonary arterial hypertension: results from the global TOPP registry	2
The utility of implantable loop recorders in patient management: an age- and indication-stratified study in the outpatient-implant era	2
Subclinical leaflet thrombosis after transcatheter aortic valve replacement: a meaningless finding? A systematic review and meta-analysis	2
Seasonal influenza vaccine uptake among patients with cardiovascular disease in Denmark, 2017–2019	2
Temporal trend analysis of rheumatic heart disease burden in high-income countries between 1990 and 2019	2
Association of autoimmune diseases with cardiomyopathy: a nationwide follow-up study from Sweden	2
Impact of treatment adherence on the effectiveness and safety of oral anticoagulants in patients with atrial fibrillation: a retrospective cohort study	2
Association of acute increases in serum creatinine with subsequent outcomes in patients with type 2 diabetes mellitus treated with sodium–glucose cotransporter 2 inhibitor or dipeptidyl peptidase-4 in	2
The cardiovascular disease burden attributable to low physical activity in the Western Pacific Region, 1990–2019: an age–period–cohort analysis of the Global Burden of Disease study	2
Cardiac rehabilitation, physical activity, and the effectiveness of activity monitoring devices on cardiovascular patients: an umbrella review of systematic reviews	2
The cost implications of a polypill for primary prevention in the TIPS-3 trial	2
Machine learning for prediction of all-cause mortality after transcatheter aortic valve implantation	2
Behavioural digital biomarkers enable real-time monitoring of patient-reported outcomes: a substudy of the multicenter, prospective observational SafeHeart study	2
Transition to adult care of young people with congenital heart disease: impact of a service on knowledge and self-care skills and correlates of a successful transition	2
Machine-learning versus traditional approaches for atherosclerotic cardiovascular risk prognostication in primary prevention cohorts: a systematic review and meta-analysis	2
Association between the magnitude of periprocedural myocardial injury and prognosis in patients undergoing elective percutaneous coronary intervention	2
Aortic regurgitation management: a systematic review of clinical practice guidelines and recommendations	2
Sex differences in clinical profile, management, and outcomes of patients hospitalized for atrial fibrillation in the United States	2
Association between Early Oral β-Blocker Therapy and Risk for In-Hospital Major Bleeding after Percutaneous Coronary Intervention for Acute Coronary Syndrome: Findings from CCC-ACS Project	2
Social determinants of health and catheter ablation after an incident diagnosis of atrial fibrillation: a Danish nationwide cohort study	2
Longitudinal risk of death, hospitalizations for atrial fibrillation, and cardiovascular events following catheter ablation of atrial fibrillation: a cohort study	2
Risk of incident cardiovascular disease among patients with gastrointestinal disorder: a prospective cohort study of 330 751 individuals	2
Estimating the impact of implementing an integrated care management approach with Atrial fibrillation Better Care (ABC) pathway for patients with atrial fibrillation in England from 2020 to 2040	2
Presentation, care, and outcomes of patients with NSTEMI according to World Bank country income classification: the ACVC-EAPCI EORP NSTEMI Registry of the European Society of Cardiology	2
Prospective follow-up in various subtypes of cardiomyopathies: insights from the ESC EORP Cardiomyopathy Registry	2
Optimization of atrial fibrillation care: management strategies and quality measures	2
Association between multimodality measures of aortic stenosis severity and quality-of-life improvement outcomes after transcatheter aortic valve replacement	2
European Society of Cardiology quality indicators for the cardiovascular pre-operative assessment and management of patients considered for non-cardiac surgery. Developed in collaboration with the Eur	2
Thirteen-year trends in cardiovascular risk in men and women with chronic coronary syndrome	2
Incident atrial fibrillation and risk of psychoactive drug redemptions and psychiatric hospital contacts: a Danish Nationwide Register-based Follow-up Study	2
Health economic evaluation of nation-wide screening programmes for atrial fibrillation in the Netherlands	2